Sodium butyrate and transforming growth factor b (TGFb 1 ) are growth inhibitory to colonic adenoma cell lines. Butyrate induces apoptosis, whereas in some adenoma cell lines, TGFb 1 can be growth inhibitory without apoptosis. In this report, we show that the adenoma cell line PC/BH/C1 undergoes apoptosis in response to TGFb 1 . Butyrate induced cell death is preceded by the induction of two markers of colonic differentiation ± alkaline phosphatase (ALP) activity and E-cadherin protein expression. However, TGFb 1 -induced apoptosis was not accompanied by induction of these differentiation markers. It is possible that the apoptosis induced by TGFb 1 in the adenoma cell line PC/BH/C1 is due to conflicting signals, as downregulation of c-myc protein in response to TGFb 1 occurs only slowly in this cell line. Development of resistance to TGFb 1 in colonic tumours may involve two separate stages ± resistance to growth inhibition and resistance to TGFb 1 -induced apoptosis. Our results indicate that sodium butyrate induces apoptosis via differentiation, but TGFb 1 induces apoptosis by a differentiationindependent mechanism. As for butyrate, the induction of Ecadherin expression is a potentially important chemopreventative action, since increased E-cadherin expression has been correlated with decreased metastatic potential. This is the first report of induction of E-cadherin by a naturally occurring factor in the diet. Butyrate may reduce tumour growth and invasion, not only as a result of the induction of apoptosis, but also through increased expression of E-cadherin.
Introduction
In the human colonic crypt, tissue homeostasis is maintained by a precise balance between an increase in cell number due to mitosis at the base of the crypt, and a decrease in cell number by cell death at the luminal surface. The regulation of colonic cell number may be influenced by growth factors endogenous to the colon, for example, transforming growth factor-b1 (TGFb 1 ). This autocrine growth inhibitor has been demonstrated to negatively regulate intestinal epithelial cell growth in vitro (Barnard et al, 1989; Hoosein et al, 1989; Manning et al, 1991; Geiser et al, 1992; Wu et al, 1992) . In addition, immunostaining for TGFb 1 protein expression in the normal human colonic mucosa has shown it to be differentially expressed within epithelial cells of the crypt, with enhanced immunoreactivity in the non-proliferating more differentiated cells in the upper parts of the crypt and an absence of expression in the lower proliferating cell compartment (Avery et al, 1993) .
In addition to endogenous growth regulators like TGFb 1 , there is evidence that dietary factors may also play an important role in growth control in the colorectum. Epidemiological studies have suggested that a diet low in fat and high in fibre could be protective against colorectal cancer (Burkitt, 1971; Howe et al, 1992) . Conversely, studies by Sandler et al (1993) have demonstrated that diets high in fat and low in fibre typical of those found in industrialised countries, increase the risk of the development of colon cancer. In the colonic lumen, dietary fibre is fermented by symbiotic bacteria producing the short-chain fatty acids butyrate, propionate and acetate as major byproducts in millimolar amounts (Cummings, 1981) . A putative role for sodium butyrate in the negative regulation of growth in the colon has been suggested by several studies that have demonstrated its antiproliferative effects on colon carcinoma cells and the induction of differentiation in these cells in vitro (Kim et al, 1982; Whitehead et al, 1986; Barnard and Warwick, 1993) . The pleiotrophic effects of butyrate have been suggested to result from the inhibition of histone deacetylase by butyrate leading to altered gene expression (Kruh et al, 1982) .
We have previously shown that sodium butyrate and TGFb 1 have growth inhibitory effects on colonic adenomaderived cell lines in vitro (Manning et al, 1991 (Manning et al, , 1993 . However, in two of the adenoma cell lines studied (S/RG/ C2 and PC/AA/C1) it has been shown that butyrate treatment induced apoptosis whereas TGFb 1 did not, suggesting that these factors may act through different growth-inhibitory pathways (Hague et al, 1993a) . In this paper, we demonstrate that TGFb 1 -mediated growth inhibition can lead to an induction of apoptosis in another adenoma-derived cell line, PC/BH/C1. This finding is consistent with a recent report by Wang et al (1995) who showed that TGFb 1 can induce apoptosis in the human colon adenoma cell line VACO-330. Therefore, TGFb 1 is growth inhibitory to colonic epithelial cells and, depending on the cell line, TGFb 1 induces apoptosis in some colorectal tumour cell lines but not others.
In vivo studies have suggested that apoptosis occurs at the luminal surface of the colonic crypt as the final step in a terminal differentiation pathway (Gavrieli et al, 1992; . Further evidence to support this has come from in vitro studies which have shown that the differentiation agent butyrate is able to induce apoptosis in colorectal tumour cell lines (Hague et al, 1993a; Heerdt et al, 1994) and that the apoptotic cells retain a marker of colonic differentiation that is expressed by the non-apoptotic population (Heerdt et al, 1994) . However, despite its clear importance, relatively little is known about the relationship between growth inhibition, differentiation and apoptosis in the colon, the factors which regulate these processes or the possible pathways to apoptosis. Although there have been a number of studies to determine the mechanism(s) of TGRb 1 induced G1 arrest little is known regarding the mechanisms by which TGFb 1 induces apoptosis (Markowitz and Roberts, 1996) . This is an important question since there is significant evidence that TGFb 1 is a negative growth regulator in the colon.
In this study, we have examined the relationship between butyrate-and TGFb 1 -mediated growth inhibition and the induction of differentiation and apoptosis. In particular, we addressed the question as to whether the TGFb 1 -induced apoptosis seen in the adenoma cell line PC/BH/C1 is via a terminal differentiation pathway or potentially by a differentiation-independent pathway, for example, due to conflicting growth signals (Askew et al, 1991; Evan et al, 1992; Shi et al, 1992) . We examined alkaline phosphatase activity, a well-documented parameter of the degree of colonic epithelial differentiation (Yamomoto and Yasuda, 1973; Herz et al, 1981; Chung et al, 1985; Henthorn et al, 1988) . Furthermore, we have used E-cadherin protein expression as an additional marker of colonic cell differentiation. Cell-cell and cell-matrix interactions play an essential role in the induction and maintenance of a differentiated epithelial cell phenotype and the expression of the cell-cell adhesion molecule, Ecadherin, has been shown to play an important role in the induction and maintenance of a differentiated colonic epithelial cell phenotype Birchmeier and Behrens, 1994) . Loss of E-cadherin expression both in vitro and in vivo has been shown to correlate with a loss of cellular differentiation Nigam et al, 1993; Pignatelli et al, 1993; Hermiston and Gordon, 1995) . In addition, E-cadherin has been demonstrated to prevent invasiveness of malignant cells (Chen and Obrink, 1991; Frixen et al, 1991; Vleminckx et al, 1991) , suggesting it may have an important role as a tumour (invasion) suppressor (Becker et al, 1994; Birchmeier, 1995) .
Thus, in this paper we examined whether apoptosis induced by two potentially important regulators of colonic epithelial cell growth, TGFb 1 and butyrate, is via a differentiation pathway and/or whether they alter the expression of the tumour (invasion) suppressor E-cadherin. These studies could have important implications for our understanding of the pathways to differentiation and apoptosis in the colon and also the potential role of these factors in chemoprevention.
Results
Sodium butyrate, but not TGFb 1 , induces expression of markers of colonic differentiation in adherent colonic adenoma-and carcinoma-derived cells To determine the relationship between growth inhibition and the induction of a more differentiated phenotype, we analyzed markers of colonic differentiation in the adenoma-derived cell lines PC/AA/C1 and S/RG/C2 and the transformed adenoma cell line PC/AA/C1/SB/10 following treatment with concentrations of sodium butyrate (1 ± 3 mM) previously shown to be growth inhibitory and to induce apoptosis (Hague et al, 1993a) . In addition, the carcinoma-derived cell line PC/JW/FI was analyzed following butyrate treatment as this cell line has previously been shown to be relatively resistant to butyrateinduced growth inhibition (Berry and Paraskeva, 1988) . Results show that in all cell lines examined, 48 h treatment with sodium butyrate resulted in a significant increase in ALP activity in adherent cells compared to controls (Figure 1 ). TGFb 1 -treatment (0.5 ± 10 ng/ml) has also been shown to be growth inhibitory to PC/AA/C1 and S/RG/C2 cells (Manning et al, 1991) . However, treatment of the above cell lines with TGFb 1 did not significantly alter the levels of ALP activity, after either 48 h (Figure 1 ) or 96 h (results not shown).
We extended these initial studies by examining an additional marker of colonic differentiation to provide a more comprehensive picture of the effects of butyrate and TGFb 1 on the induction of differentiation. Thus, adherent cells were examined for expression of the cell-cell adhesion protein E-cadherin following SDS ± PAGE and Western blotting with the HECD-1 antibody. Figure 2 shows a dose-dependent increase in E-cadherin expression in PC/ AA/C1 following treatment with concentrations of sodium butyrate (1 ± 3 mM). Analogous results were obtained with the adenoma cell line S/RG/C2, the transformed adenoma cell line PC/AA/C1/SB10 and the carcinoma cell line PC/ JW/FI (data not shown).
TGFb 1 treatment for 96 h did not result in any detectable change in the expression of E-cadherin protein in the two adenoma-derived cell lines PC/AA/C1 and S/RG/C2 that have previously been demonstrated to be sensitive to its antiproliferative effects (Manning et al, 1991) , but are not induced to apoptose following treatment (Hague et al, 1993a) . The results obtained for S/RG/C2 are shown in Figure 3 . PC/AA/C1 gave similar results (data not shown).
The results of the E-cadherin protein expression studies correlate with the ALP activity assays, and suggest that growth inhibition induced by sodium butyrate leads to differentiation in these adherent cells. However, PC/AA/C1 and S/RG/C2 could be growth inhibited by TGFb 1 without the induction of two markers of colonic differentiation. These two cell lines did not undergo apoptosis in response to TGFb 1 .
Both spontaneously-derived and butyrate-induced apoptosis occurs via a pathway of terminal differentiation
In vivo, apoptosis is seen amongst terminally differentiated cells at the luminal surface of the colonic crypt (Gavrieli et al, 1992; Hall et al, 1994) . In our in vitro cell culture system, cells which spontaneously detach from the tissue culture flask during routine cell culture and float in the medium have previously been shown to be apoptotic (Hague et al, 1993a; Bracey et al, 1995) . This apoptotic population has previously been demonstrated to increase in the adenoma-derived cell lines PC/AA/C1 and S/RG/C2 and PC/AA/ C1/SB10 following treatment with sodium butyrate, but not with TGFb 1 (Hague et al, 1993a (Hague et al, , 1995 . To determine whether spontaneous and butyrate-induced floating, apoptotic cells were the end point of a differentiation pathway (i.e. were terminally differentiated), adherent and floating After treatment with butyrate, ALP activity was increased in the adherent cells, suggesting the induction of differentiation by butyrate (Figure 1) . Levels of ALP activity in the spontaneously-derived apoptotic cell population were generally higher than levels observed in adherent cells of the four cell lines examined, in agreement with previous observations by Heerdt et al (1994) . For example, at the 72 h time point the ALP activity in the floating cells was 3.4-fold higher than the controls for PC/AA/C1, 6.7-fold higher for PC/AA/C1/SB/10, 1.7-fold higher for S/RG/C2 and 6.0-fold higher for PC/JW/FI. These results suggest that cells may spontaneously apoptose during routine culture as the end point of a pathway of terminal differentiation. Furthermore, in butyrate-treated cultures, levels of ALP activity were similarly increased in floating apoptotic cells compared to adherent cells (data not shown). The apoptotic population in these conditions is comprised of both spontaneously-derived and butyrate-induced apoptotic cells. A level of ALP activity in the apoptotic population that is similar or higher than that observed in adherent, non-apoptotic cells, suggests that these apoptotic cells are derived from the differentiated population of adherent cells.
TGFb 1 induces apoptosis in responsive cells via a differentiation-independent pathway
Although the two adenoma cell lines examined previously (PC/AA/C1 and S/RG/C2) did not apoptose following treatment with TGFb 1 (Hague et al, 1993a) , our recent studies have demonstrated that a further adenoma-derived cell line, PC/BH/C1, is responsive to both TGFb 1 -induced growth inhibition (approximately 50% growth inhibition compared to controls at 72 h) and apoptosis (Figure 4) . Note that the PC/BH/C1 cell line exhibits high levels of spontaneous apoptosis (Figure 4 ) and undergoes apoptosis in response to 1 ± 4 mM butyrate (this dose range gives a 2 ± 4-fold increase in the percentage of cells floating compared to the controls after a 96 h treatment). As for the other adenoma cell lines, both spontaneous and butyrate-induced floating apoptotic cells had high levels of ALP activity and the attached cells of butyrate treated cultures had higher activity than the controls. Therefore, PC/BH/C1 is responsive to butyrateinduced differentiation and apoptosis, as shown previously in several other colonic tumour cell lines (Hague et al, 1993 (Hague et al, , 1995 Heerdt et al, 1994) . However, in response to TGFb 1 analysis of markers of colonic differentiation in these cells revealed no detectable differences in either E-cadherin expression ( Figure 5 ) or ALP activity (Figure 6 ) compared to controls. Thus, these results suggest that, unlike butyrate, TGFb 1 may induce apoptosis in these cells via a pathway separate from the induction of markers of colonic differentiation.
Discussion
The maintenance of normal tissue homeostasis in the colonic crypt is dependent upon a precise balance between proliferation, differentiation and cell death. A breakdown in this balance is believed, at least in part, to be important in the uncontrolled growth characteristic of colonic carcinogenesis. This deregulation of growth can occur through a reduced response to growth inhibition by negative regulators of growth such as TGFb 1 (Manning et al, 1991; Markowitz et al, 1995) and/or due to reduced levels of apoptosis (Hague et al, 1993b; Bedi et al, 1995) .
Despite evidence that the end point of the colonic differentiation pathway in vivo is apoptosis at the luminal surface (Gavrieli et al, 1992; Hall et al, 1994) , relatively little is known about the relationship between growth inhibition, differentiation and apoptosis in the colon, the factors which regulate these processes, or possible different pathways to apoptosis. To examine the relationship between differentia- tion and apoptosis in colonic cells, we have examined whether TGFb 1 -and butyrate-induced growth inhibition and/or apoptosis are via differentiation dependent or independent pathways. We have used ALP activity and E-cadherin protein expression as markers of colonic differentiation. Furthermore, we have addressed these questions using adenoma cell lines as well as carcinoma cell lines, since the former retain certain features of normal cells, such as being non-tumorigenic and retaining sensitivity to TGFb 1 -induced growth inhibition (Manning et al, 1991; Wang et al, 1995) . In this paper, we have demonstrated that sodium butyrate inhibits growth and induces apoptosis in colonic adenoma-and carcinoma-derived cell lines and this is accompanied by the induction of a more differentiated phenotype. The ability of the naturally occurring dietary factor, butyrate, to increase the expression of E-cadherin protein is of interest since increased E-cadherin expression correlates with decreased tumour invasiveness (Frixen et al, 1991) . Indeed, a recent study by Barshishat et al (1996) has demonstrated that butyrate treatment abolished the liver colonising ability of human colon cancer cell lines previously shown to have high liver metastasising activity. Thus, butyrate, in addition to promoting differentiation and apoptosis, may have a role in protecting against tumour progression by reducing the invasiveness of a tumour through increased expression of E-cadherin.
In contrast to the effects of butyrate, there is no evidence from these studies that TGFb 1 induces a more differentiated phenotype in colonic adenoma cells, whether it induces apoptosis or not. Although both butyrate and TGFb 1 are growth inhibitory to adenoma cells, these results suggests that they may act through different growth regulatory pathways. Previous studies have suggested that TGFb 1 may inhibit intestinal epithelial cell growth by induction of a terminal differentiation pathway (Kurokowa et al, 1987; Hott and Baird, 1986) . However, subsequent studies by Barnard et al (1989) did not reveal any evidence of a direct role for TGFb 1 in enterocyte differentiation in the IEC-6 intestinal cell line, suggesting that TGFb 1 may function together with other stimuli in vivo to induce a differentiation programme. Our results may reflect the in vivo role of TGFb 1 in the colon, by inducing a growth arrest in responsive cells which then require additional signals from other growth and/or dietary factors, e.g. sodum butyrate, to proceed through a differentiation programme. Indeed, the presence of TGFb 1 protein expression in the non-proliferating region of the human colonic cryptic (Avery et al, 1993) , may suggest a role for the growth factor in mediating a stable growth arrest which is a prerequisite for differentiation. In addition, differentiating agents such as HMBA, retinoid acid and sodium butyrate can induce TGFb 1 expression (Glick et al, 1989; Schroy et al, 1990; Barnard and Warwick, 1993) suggesting some interaction between these factors in the maintenance of a differentiated phenotype. Thus, it seems plausible that the role of TGFb 1 in the human colonic crypt may be in the maintenance of a non-proliferative state, to allow subsequent induction and stabilisation of a differentiated phenotype by additional growth and/or dietary factors and through interactions with the extracellular matrix (ECM).
Although it is unclear why TGFb 1 induces apoptosis in some adenoma cell lines and not others, the response to TGFb 1 may depend on the degree of sensitivity to TGFb 1 -induced growth inhibition which may be determined, in part, by the particular genes mutated in the adenoma cells . For example, it is plausible that TGFb 1 may induce an apoptotic response in PC/BH/C1 by eliciting conflicting growth signals in these cells, for example by an inability to downregulate Myc expression, as has been suggested by studies in fibroblasts (Evan et al, 1992) , myeloid (Askew et al, 1991) and T cells (Shi et al, 1991) . Indeed, Western blotting analysis of Myc expression in PC/ BH/C1 cells following treatment with TGFb 1 showed a slower downregulation of expression in treated cells (after 48 h, data not shown) compared to the rapid downregulation observed in PC/AA/C1 and S/RG/C2 (after 4 h, data not shown). These results may, therefore, suggest some deregulation of Myc in these cells and that the apoptotic response to TGFb 1 observed in PC/BH/C1 may be along a pathway that is distinct from a terminal differentiation pathway, possibly due to conflicting growth signals. Whatever the mechanism by which TGFb 1 induces apoptosis in colonic epithelial cells, the development of resistance is important in colorectal tumorigenesis (Manning et al, 1991; Markowitz et al, 1995) . There may be two stages to the development of TGFb 1 resistance ± resistance to growth inhibition and resistance to TGFb 1 -induced apoptosis.
In summary, we have demonstrated that butyratemediated apoptosis occurs as the end point of a terminal differentiation pathway, thereby potentially mimicking in vivo processes in which differentiated cells at the top of the colonic crypt undergo apoptosis (Gavrieli et al, 1992; . In addition, we have demonstrated that sodium butyrate may play an important role in growth regulation in the colon, not only in inducing apoptosis, but also by protecting against tumour invasion by inducing expression of the tumour invasion suppressor E-cadherin. This is the first report of an endogenous dietary factor increasing the expression of E-cadherin which, together with the growth inhibitory and apoptosis inducing effects of butyrate and TGFb 1 , could have important implications for cancer chemoprevention. In contrast, TGFb 1 -treatment does not induce differentiation in adenoma cells that are responsive to its antiproliferative and, in some cases, apoptosisinducing efects. Thus, although both sodium butyrate and TGFb 1 are clearly growth inhibitory to colonic epithelial cells, they may have divergent and/or complementing roles in the regulation of growth in the colonic crypt in vivo.
Materials and Methods

Cell culture
The human adenoma cell lines used in this study, S/RG/C2, PC/BH/C1 and PC/AA/C1, were clonogenic variants of the sporadically derived S/ RG cell line (Paraskeva et al, 1989a) , and the PC/BH and PC/AA derived cell lines from patients with the inherited condition familial adenomatous polyposis (Paraskeva et al, 1984 (Paraskeva et al, , 1989b respectively. Two adenocarcinoma cell lines were also investigated. PC/JW/FI is a 3T3 feeder independent variant of the carcinoma cell line PC/JW, derived from a FAP patient and previously described (Paraskeva et al, 1984) . PC/AA/C1/SB/10 is a tumorigenic in vitro transformed derivative of the PC/AA/C1 cell line (Williams et al, 1990) . The PC/ AA/C1 and PC/BH/C1 adenoma cell lines are both wild type for p53 whereas the S/RG adenoma cell line has a mutant p53 (Baker et al, 1989; Williams et al, 1993) . All the adenoma cell lines are TGFb 1 sensitive and non tumorigenic in athymic nude mice wheres PC/JW and PC/AA/C1/SB/10 are TGFb 1 resistant and tumorigenic (Paraskeva et al, 1984; Williams et al, 1990; Manning et al, 1991) .
Cells were routinely cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% foetal bovine serum (bath tested), hydrocortisone sodium succinate (1 mg/ml), insulin (0.2 units/ ml), glutamine (2 mM), penicillin (100 units/ml) streptomycin (100 mg/ ml). Cells were grown at 378C in a 5% CO 2 air incubator.
Measurement of apoptosis
We and others (Hague et al, 1993; Heerdt et al, 1994; Tsuijii and DuBois, 1995) have previously reported that during routine cell culture, epithelial cells spontaneously detach from the tissue culture flask and float in the medium. These detached cells have been demonstrated to be apoptotic (Hague et al, 1993a) both morphologically using acridine orange staining (Gregory et al, 1991) and biochemically by internucleosomal fragmentation of the DNA to produce a DNA ladder on an electrophoretic gel (Wyllie, 1980) . The level of apoptosis has been demonstrated to increase following treatment with sodium butyrate, but not with TGFb 1 , in the two original adenoma cell lines analyzed, PC/AA/C1 and S/RG/C2 (Hague et al, 1993a) . However, our recent studies presented here have shown that the adenoma cell line PC/BH/C1 is sensitive to TGFb 1 -induced apoptosis.
Treatment with sodium butyrate
The two adenoma-derived cell lines, PC/AA/C1 and S/RG/C1, the tumorigenic transformed adenoma cell line PC/AA/C1/SB10 and the carcinoma-derived cell line PC/JW/FI were used in experiments to determine the effects of sodium butyrate on expression of markers of colonic differentiation. PC/JW/FI and PC/AA/C1/SB10 have previously been demonstrated to be relatively insensitive to butyrate-induced growth inhibition (Berry and Paraskeva, 1988; Williams et al, 1990) and apoptosis (Hague et al, 1995) . Cells were trypsinised, and seeded in triplicate at 2610 6 cells per T25 flask in standard culture medium. After 72 h when the cells were in exponential growth phase, the medium was replaced with fresh medium containing concentrations of sodium butyrate (1 ± 3 mM) previously demonstrated to produce growth inhibition (Hague et al, 1993a) and arrest in G1 phase of the cell cycle (data not shown). Cells were treated for 48 h for analysis of E-cadherin protein expression and 48, 72 and 96 h for the alkaline phosphatase activity study.
Treatment with TGFb 1
The adenoma-derived cell lines PC/AA/C1, S/RG/C2 were used in experiments to investigate the effect of TGFb 1 on E-cadherin expression and alkaline phosphatase activity. These cell lines have previously been demonstrated to be sensitive to the antiproliferative effects of TGFb 1 (Manning et al, 1991) and are arrested in the G1 phase of the cell cycle following treatment (data not shown), but are not induced to apoptose following treatment (Hague et al, 1993a) . More recent studies have shown that the adenoma-derived cell line PC/BH/C1 is sensitive to both TGFb 1 -mediated growth inhibition and apoptosis ( Figure 5 ).
Cells were trypsinised and seeded at a density of 2610 6 cells per T25 flask in standard culture medium and treated with a range of concentrations of TGFb 1 (0.5 ± 10 ng/ml) in fresh medium after 72 h when cells were in exponential growth phase. Initially, 48 h of treatment resulted in no change in E-cadherin protein expression in PC/AA/C1 and S/RG/C2 (data not shown), so a longer treatment time of 96 h was used in subsequent experiments with these cell lines. Ecadherin expression in PC/BH/C1 was analyzed after 72 h of treatment, since this was the time point at which the greatest induction of apoptosis occurred. All the cell lines examined were treated for 48, 72 and 96 h for analysis of alkaline phosphatase activity.
Immunoblotting E-cadherin is a transmembrane protein with a large extracellular domain involved in mediating homotypic cell-cell binding. In order to maintain the structure of the full-length E-cadherin protein for detection by immunoblotting, cells were scraped from the tissue culture flask rather than trypsinised. Cell number was estimated from trypsinising and counting duplicate flasks. Cells to be used for sample preparation were rinsed twice with PBS and 100 ml lysis buffer (0.125 M Tris-HCl pH 6.8, 4% SDS, 0.2% glycerol, 2 mM EDTA, 1.43 M bmercaptoethanol) per 1610 6 cells was added. The cells were removed by gentle scraping and kept on ice. A further 50 ml of lysis buffer per 1610 6 cells was added to the flask to remove any remaining cells. Hence, the final concentration was 1610 6 cells per 150 ml of lysis buffer. Samples were boiled for 10 min with periodic vortexing then placed on ice for 5 min. The supernatant was removed and microfuged at 13 000 r.p.m. for 3 min. The samples were aliquoted at 150 ml and stored at 7708C. Before SDS ± PAGE analysis, 15 ml of lysis buffer with bromophenol blue (10 mg) was added and the samples were boiled for 5 min.
Samples were subjected to SDS ± PAGE (7.5% acrylamide for Ecadherin) following the method of Laemmli (1970) and transferred to a polyvinyldifluoride membrane (PVDF; Millipore) by electroblotting for a minimum of 5 h (using transfer buffer of 192 mM glycine, 25 mM Tris with 20% methanol). The membrane was blocked for at least 1 h with milk block (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 5% non fat dried milk) and probed with the E-cadherin monoclonal antibody (HECD-1, gift from Sir Walter Bodmer, ICRF, London) diluted 1 : 100 with milk block, overnight at 48C. Following the primary incubation, the membrane was washed twice in milk block buffer for 10 min, then twice in Tween buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.2% Tween) for 10 min, followed by a final 10 min wash in milk block buffer. The membrane was probed with goat anti-mouse IgG horseradish peroxidase conjugate (Sigma) at a concentration of 1 : 1000 in milk block buffer for 1 h at 48C. Following one 20 min wash in milk block buffer and one 10 min wash in Tween buffer, the membrane was rinsed in distilled water and peroxidase activity was visualised using enhanced chemiluminescence (ECL: Amersham).
Alkaline phosphatase activity
Alkaline phosphatase (ALP) activity was used as an additional marker of the degree of colonic differentiation induced by either sodium butyrate or TGFb 1 in the cell lines studied. Attached and floating cells were washed and lysed with 0.25% sodium deoxycholate essentially as described by Herz et al (1981) . ALP activity was determined using the Sigma Diagnostics ALP reagent (No. 245). Total cellular protein content of the samples was determined in a microassay procedure as described by Bradford (1976) using the Coomassie Protein Assay Reagent Kit (Pierce). ALP activity was calculated as units of activity per mg of protein.
